Li L - Search Results

1

ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model.

Schuster-Gaul S, Geisler LJ, McGeough MD, Johnson CD, Zagorska A, Li L, Wree A, Barry V, Mikaelian I, Jih LJ, Papouchado BG, Budas G, Hoffman HM, Feldstein AE. Schuster-Gaul S, et al. Among authors: li l. JCI Insight. 2020 Jan 30;5(2):e123294. doi: 10.1172/jci.insight.123294. JCI Insight. 2020. PMID: 31996485 Free PMC article.

2

Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells.

Li L, Barry V, Daffis S, Niu C, Huntzicker E, French DM, Mikaelian I, Lanford RE, Delaney WE 4th, Fletcher SP. Li L, et al. J Hepatol. 2018 May;68(5):912-921. doi: 10.1016/j.jhep.2017.12.008. Epub 2017 Dec 14. J Hepatol. 2018. PMID: 29247724 Free PMC article.

3

Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.

Bates J, Vijayakumar A, Ghoshal S, Marchand B, Yi S, Kornyeyev D, Zagorska A, Hollenback D, Walker K, Liu K, Pendem S, Newstrom D, Brockett R, Mikaelian I, Kusam S, Ramirez R, Lopez D, Li L, Fuchs BC, Breckenridge DG. Bates J, et al. Among authors: li l. J Hepatol. 2020 Oct;73(4):896-905. doi: 10.1016/j.jhep.2020.04.037. Epub 2020 May 4. J Hepatol. 2020. PMID: 32376414 Free article.

4

PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors.

Yahiaoui A, Meadows SA, Sorensen RA, Cui ZH, Keegan KS, Brockett R, Chen G, Quéva C, Li L, Tannheimer SL. Yahiaoui A, et al. Among authors: li l. PLoS One. 2017 Feb 8;12(2):e0171221. doi: 10.1371/journal.pone.0171221. eCollection 2017. PLoS One. 2017. PMID: 28178345 Free PMC article.

5

Gene expression profiling of human tissue-resident immune cells: Comparing blood and liver.

Boeijen LL, van Oord GW, Hou J, van der Heide-Mulder M, Gaggar A, Li L, Fletcher SP, de Knegt RJ, Boonstra A. Boeijen LL, et al. Among authors: li l. J Leukoc Biol. 2019 Mar;105(3):603-608. doi: 10.1002/JLB.6AB0718-278R. Epub 2018 Nov 27. J Leukoc Biol. 2019. PMID: 30480838 Free PMC article. Clinical Trial.

6

Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents.

Goedeke L, Bates J, Vatner DF, Perry RJ, Wang T, Ramirez R, Li L, Ellis MW, Zhang D, Wong KE, Beysen C, Cline GW, Ray AS, Shulman GI. Goedeke L, et al. Among authors: li l. Hepatology. 2018 Dec;68(6):2197-2211. doi: 10.1002/hep.30097. Hepatology. 2018. PMID: 29790582 Free PMC article.

7

Reply to Yan and Muller, "Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver".

Murakami E, Bilello J, Li R, Li L, Porter D, Humeniuk R, Mackman R, Cihlar T, Osinusi A, Feng J. Murakami E, et al. Among authors: li l, li r. Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0139421. doi: 10.1128/AAC.01394-21. Epub 2021 Aug 9. Antimicrob Agents Chemother. 2021. PMID: 34370585 Free PMC article. No abstract available.

8

Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection.

Montanari NR, Ramírez R, Aggarwal A, van Buuren N, Doukas M, Moon C, Turner S, Diehl L, Li L, Debes JD, Feierbach B, Boonstra A. Montanari NR, et al. Among authors: li l. J Hepatol. 2022 Aug;77(2):332-343. doi: 10.1016/j.jhep.2022.02.016. Epub 2022 Feb 24. J Hepatol. 2022. PMID: 35218813 Free article.

9

Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.

Daffis S, Balsitis S, Chamberlain J, Zheng J, Santos R, Rowe W, Ramakrishnan D, Pattabiraman D, Spurlock S, Chu R, Kang D, Mish M, Ramirez R, Li L, Li B, Ma S, Hung M, Voitenleitner C, Yon C, Suresh M, Menne S, Cote P, Delaney WE 4th, Mackman R, Fletcher SP. Daffis S, et al. Among authors: li l, li b. Hepatology. 2021 Jan;73(1):53-67. doi: 10.1002/hep.31255. Epub 2020 Nov 27. Hepatology. 2021. PMID: 32246499 Free PMC article.

10

Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection.

Burdette D, Hyrina A, Song Z, Beran RK, Cheung T, Gilmore S, Kobayashi T, Li L, Liu Y, Niedziela-Majka A, Medley J, Mehra U, Morganelli P, Novikov N, Niu C, Tam D, Tang J, Wang J, Yue Q, Fletcher SP, Holdorf MM, Delaney WE 4th, Feierbach B, Lazerwith S. Burdette D, et al. Among authors: li l. Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0134822. doi: 10.1128/aac.01348-22. Epub 2022 Dec 15. Antimicrob Agents Chemother. 2023. PMID: 36519892 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,635 results

Search Page

Filters